A citation-based method for searching scientific literature

M S Greenblatt, W P Bennett, M Hollstein, C C Harris. Cancer Res 1994
Times Cited: 3283







List of co-cited articles
383 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


p53 mutations in human cancers.
M Hollstein, D Sidransky, B Vogelstein, C C Harris. Science 1991
18


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7


Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
6

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V Tavtigian, Pierre Hainaut, Magali Olivier. Hum Mutat 2007
6

Mutant p53 in cancer: new functions and therapeutic opportunities.
Patricia A J Muller, Karen H Vousden. Cancer Cell 2014
940
6


Surfing the p53 network.
B Vogelstein, D Lane, A J Levine. Nature 2000
6

A genetic model for colorectal tumorigenesis.
E R Fearon, B Vogelstein. Cell 1990
5

p53 and human cancer: the first ten thousand mutations.
P Hainaut, M Hollstein. Adv Cancer Res 2000
750
5

Mutant p53: one name, many proteins.
William A Freed-Pastor, Carol Prives. Genes Dev 2012
772
5

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin, Monica Hollstein, Graham Byrnes, Jiri Zavadil, Magali Olivier. Hum Mutat 2016
422
5

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
5

WAF1, a potential mediator of p53 tumor suppression.
W S el-Deiry, T Tokino, V E Velculescu, D B Levy, R Parsons, J M Trent, D Lin, W E Mercer, K W Kinzler, B Vogelstein. Cell 1993
5

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
4

Cell-cycle checkpoints and cancer.
Michael B Kastan, Jiri Bartek. Nature 2004
4


The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
4


The first 30 years of p53: growing ever more complex.
Arnold J Levine, Moshe Oren. Nat Rev Cancer 2009
4

p53 in health and disease.
Karen H Vousden, David P Lane. Nat Rev Mol Cell Biol 2007
4

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
4

TP53 mutations in human cancers: origins, consequences, and clinical use.
Magali Olivier, Monica Hollstein, Pierre Hainaut. Cold Spring Harb Perspect Biol 2010
4

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
4

Mdm2 promotes the rapid degradation of p53.
Y Haupt, R Maya, A Kazaz, M Oren. Nature 1997
4



Genetic instability in colorectal cancers.
C Lengauer, K W Kinzler, B Vogelstein. Nature 1997
3

Cell cycle, CDKs and cancer: a changing paradigm.
Marcos Malumbres, Mariano Barbacid. Nat Rev Cancer 2009
3

Clinical implications of the p53 tumor-suppressor gene.
C C Harris, M Hollstein. N Engl J Med 1993
3

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
3


Divorcing ARF and p53: an unsettled case.
Charles J Sherr. Nat Rev Cancer 2006
438
3

Mechanisms underlying mutational signatures in human cancers.
Thomas Helleday, Saeed Eshtad, Serena Nik-Zainal. Nat Rev Genet 2014
496
3


Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Gerd P Pfeifer, Mikhail F Denissenko, Magali Olivier, Natalia Tretyakova, Stephen S Hecht, Pierre Hainaut. Oncogene 2002
725
3

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.
Aziz Sancar, Laura A Lindsey-Boltz, Keziban Unsal-Kaçmaz, Stuart Linn. Annu Rev Biochem 2004
3

The Cancer Genome Atlas Pan-Cancer analysis project.
John N Weinstein, Eric A Collisson, Gordon B Mills, Kenna R Mills Shaw, Brad A Ozenberger, Kyle Ellrott, Ilya Shmulevich, Chris Sander, Joshua M Stuart. Nat Genet 2013
3


In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Lyubomir T Vassilev, Binh T Vu, Bradford Graves, Daisy Carvajal, Frank Podlaski, Zoran Filipovic, Norman Kong, Ursula Kammlott, Christine Lukacs, Christian Klein,[...]. Science 2004
3


p53 ubiquitination: Mdm2 and beyond.
Christopher L Brooks, Wei Gu. Mol Cell 2006
643
3

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
M Luana Poeta, Judith Manola, Meredith A Goldwasser, Arlene Forastiere, Nicole Benoit, Joseph A Califano, John A Ridge, Jarrard Goodwin, Daniel Kenady, John Saunders,[...]. N Engl J Med 2007
502
3

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
3


Mutational processes molding the genomes of 21 breast cancers.
Serena Nik-Zainal, Ludmil B Alexandrov, David C Wedge, Peter Van Loo, Christopher D Greenman, Keiran Raine, David Jones, Jonathan Hinton, John Marshall, Lucy A Stebbings,[...]. Cell 2012
3

UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
Hong Wu, Scott L Pomeroy, Manuel Ferreira, Natalia Teider, Juliana Mariani, Keiichi I Nakayama, Shigetsugu Hatakeyama, Victor A Tron, Linda F Saltibus, Leo Spyracopoulos,[...]. Nat Med 2011
82
3


Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda, De-Chen Lin, Yassen Assenov, Christoph Plass, H Phillip Koeffler. Genome Res 2018
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.